The Amgen Safety Net Foundation is designed to assist those patients who are uninsured and with limited or no financial resources. Eligibility is based on US residency, insurance status and income criteria.

How to Apply

Please either download the application below (if available) or go to the program website for more information on how to apply. Once you fill out your application, send it to the address on the application. Remember not to send program applications to PPA.

Product(s) Covered by Program

  • A

    • Aranesp® (darbepoetin alfa)
  • B

    • BLINCYTO® (blinatumomab) for injection
  • C

    • Corlanor® (ivabradine) tablets
  • E

    • Enbrel® (etanercept)
    • EPOGEN® (EPOETIN ALFA) for dialysis use only
  • I

    • IMLYGIC® (talimogene laherparepvec) suspension for injection
  • K

    • Kyprolis® (carfilzomib) for injection
  • N

    • Neulasta® (pegfilgrastim)
    • Neupogen®
    • Nplate® (romiplostim)
  • P

    • Parsabiv™
    • Prolia® (denosumab) injection for bone health
    • Prolia® (denosumab) injection for bone health and oncology
  • R

    • Repatha® (evolocumab)
  • S

    • Sensipar® (cinacalcet)
  • V

    • Vectibix® (panitumumab) injection
  • X

    • XGEVA® (denosumab)